Hook / Thesis
Salesforce (CRM) has been punished hard: the stock sits just above its 52-week low ($146.32 on 06/22/2026) after collapsing roughly 59% from the 2024 peak. That sell-off has left the business trading at a sensible multiple versus its cash flow and earnings profile. Free cash flow of $14.66 billion and an enterprise value of $153.29 billion create room for significant buybacks even after continued AI investment or M&A. In short - the company can grow its AI stack, fund strategic tuck-ins like the recent $3.6B Fin acquisition, and return capital to shareholders. That optionality looks attractive where the market is pricing the business today.
Two-sentence thesis: Buy CRM at $155.00 for a tactical rebound and medium-term re-rating driven by buybacks and continued AI monetization. The fundamental cushion is real - solid free cash flow, a mid-teens P/E and EV/EBITDA near 10.4 create a margin of safety that should limit downside from current levels.
Why the market should care
Salesforce is the dominant enterprise CRM and customer-engagement platform. Its suite spans sales automation, customer service, marketing automation, digital commerce and an extensible platform for industry-specific solutions. In an era where enterprise software must incorporate generative AI, Salesforce's position as the embedded CRM for large enterprises and its existing integrations with leading AI providers (including a sizable stake in Anthropic) mean it can translate AI investments into recurring revenue and higher wallet share.
From a shareholder-return perspective, the business generates sizeable free cash flow: $14.66B reported in the latest snapshot. That level of FCF against an enterprise value of $153.29B implies a realistic runway to fund both growth initiatives and buybacks without materially increasing leverage. The balance sheet shows debt-to-equity of ~1.15 - leverage exists but is manageable for a company of this scale.
What the numbers say
- Market capitalization sits around $126.9B based on the current snapshot; alternate price-based computations showed $122.9B using the $150.12 close on 06/22/2026. Either way, Salesforce is a large-cap, but not frothy, technology company at present.
- Reported earnings per share are $9.80 with a trailing P/E near 15.3 (using the $150-level close). The snapshot P/E reads ~17.4 at $155, still a single-digit-to-low-double-digit multiple that is modest for a market leader in enterprise software.
- Valuation multiples: price-to-sales ~2.87, EV/EBITDA ~10.36 and price-to-free-cash-flow ~8.39. These are not expensive given the business’ scale and recurring-revenue characteristics.
- Dividend: Salesforce pays a $0.44 quarterly dividend (ex-dividend 06/11/2026), a modest yield that is unlikely to be the primary capital-return mechanism. Buybacks are the more likely lever to boost shareholder returns.
- Technicals show the stock is oversold but not capitulated: 10-day SMA $161.68, 50-day SMA $177.49, RSI ~35.5 and MACD indicating bearish momentum. That combination historically fits a tactical entry for mean-reversion trades with a longer-term catalyst in place.
Valuation framing - why this is attractive
At the current price point, Salesforce offers a margin of safety compared with its historical highs and the likely long-term cash flows from a sticky SaaS business. EV/EBITDA at ~10.4 and price-to-free-cash-flow under 9 are compelling for a company delivering predictable recurring revenues and high returns on equity (~23.4%). Even allowing for continued investment in AI and selective M&A (Salesforce paid $3.6B to acquire Fin on 06/18/2026), the balance between investment and buybacks is favorable: the company can both expand product capabilities and repurchase shares without a destructive capital structure shift.
Qualitatively, a company with strong platform effects and embedded customer relationships should trade at a premium to cyclical software peers over time. Today, however, it trades at mid-market software multiples - an investor can buy optionality on an AI-enabled re-acceleration plus the immediate upside from share repurchases.
Catalysts (2-5)
- Buyback announcement or accelerated repurchase program - given $14.66B in FCF and a moderate leverage profile, any sizable buyback would be a direct rerating catalyst.
- AI monetization milestones - improved ARPU from Agentforce and deeper Anthropic/Claude integrations that translate into subscription/consumption revenue growth.
- Positive quarterly results showing margin expansion and FCF conversion - confirmation that investments are not cannibalizing cash generation.
- Macro tailwinds - cooling rate-hike expectations (oil/energy-driven disinflation) could lift software multiples; there was commentary on rate relief benefiting software names recently.
Trade plan - actionable entry, stops and targets
The trade plan below assumes you buy into a tactical rebound supported by buyback optionality and improving AI monetization. I recommend position sizing appropriate to your risk tolerance; treat this as a medium-conviction swing-to-position trade.
| Action | Price | Horizon | Rationale |
|---|---|---|---|
| Entry | $155.00 | Mid term (45 trading days) | Buy near intraday resistance; recent pivot off 52-week low creates asymmetric upside vs downside. |
| Stop | $140.00 | Applies at all horizons | Invalidates the tactical thesis - breakdown below recent low and further de-rating likely. |
| Primary target | $220.00 | Long term (180 trading days) | Re-rating toward a mid-20s P/E or a partial recovery toward the lower half of prior trading range. |
| Secondary/near-term target | $185.00 | Short term (10 trading days) | Mean-reversion to the 10-20 day moving average zone; opportunity to take partial profits. |
Notes on horizons: short term (10 trading days) is useful for quick mean-reversion trades to $185. Mid term (45 trading days) is the recommended window to evaluate buyback announcements or quarterly beats, and long term (180 trading days) is the horizon for a fuller fundamental re-rating if AI monetization and buybacks are both evident.
Risks and counterarguments
No investment is without risk; here are the principal downsides and one explicit counterargument to the bullish case.
- Macro / rate risk: If inflation surprises on the upside and the Fed stays hawkish, software multiples can compress further. CRM is not immune to multiple contraction even with solid cash flow.
- Execution risk on AI: Heavy AI investment can be expensive. Oracle's announced AI capital spend ($70B in 2027 in a related report) shows how costly this race can be; misallocated capex or weak monetization would erode FCF and sentiment.
- Leverage and balance-sheet flexibility: Debt-to-equity sits around 1.15. A big buyback program funded with additional debt could be criticized if growth slows, putting pressure on credit metrics.
- Sentiment and momentum: Technicals are bearish (MACD negative, RSI ~35.5). Momentum-driven selling could push CRM below the recent low before fundamentals matter again.
- Competition and structural shifts: ServiceNow, Oracle and other platform players are competing aggressively in AI and workflow automation. Faster-than-expected share loss or aggressive pricing could depress long-term margins.
Counterargument: A structural bear case argues Salesforce's decline is not just a valuation reset but a signal of slowing enterprise spend and tougher competitive dynamics. That view expects the stock to trade materially below today's levels and only recover after a multi-quarter reset. This is plausible; if Salesforce's revenue growth materially decelerates or FCF drops sharply, the buyback optionality will be insufficient to sustain a rerating.
Why I still buy despite the counterargument
The counterargument rests on two events that are currently unlikely together: (1) a sustained collapse in enterprise software spending while (2) Salesforce simultaneously losing its product leadership and customer lock-in. The company’s scale, diversified product set and recurring-revenue model make both events plausible but not the base case. Given current multiples (P/E ~15-17 depending on the reference price and EV/EBITDA ~10.4) and the company’s $14.66B in FCF, downside is cushioned relative to the upside from buybacks and AI monetization. That asymmetry is the basis for the buy recommendation.
What would change my mind
- A steady decline in free cash flow or an unexpected impairment charge tied to AI investments or acquisitions.
- Evidence that enterprise CRM customers are materially cutting spend or switching platforms en masse.
- A highly dilutive capital decision: large equity issuance or buybacks funded with aggressive new debt that materially worsens credit metrics.
Conclusion
Salesforce is attractively priced for a tactical buy. The business prints meaningful free cash flow ($14.66B) and trades at reasonable multiples (P/E in the mid-teens, EV/EBITDA ~10.36). That creates a credible pathway to shareholder returns through buybacks and continued monetization of AI features. Enter at $155.00, use a stop at $140.00, and target $220.00 over a 180-trading-day window while monitoring buyback announcements, AI revenue traction and cash flow conversion. If the company proves it can accelerate ARPU from AI services while maintaining FCF, the stock should re-rate higher; if FCF collapses or the company meaningfully loses customer wallet share, it may be time to exit and reassess.
Key dates referenced
- 06/18/2026 - Salesforce acquired Fin for $3.6B (strategic tuck-in to broaden offerings).
- 06/11/2026 - ex-dividend date for the most recent $0.44 quarterly dividend payment.